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Introduction
 Cancer is a public health problem in the world and 
a major cause of death in the world. Around 13% of all 
deaths due cancer occured in 2008, and more than 70% 
of all death due to cancer occured in developing countries 
(WHO, 2011). The disease is associated with uncontrolled 
rapid growth of abnormal cells in the body. They have 
the capacity to invade the healhty surrounding tissue and 
spread to other organs, known as metastatis (Hanahan and 
Weinberg, 2011).
 There are several approaches used for treating cancer 
including chemotherapy. One of the most popular 
chemotherapeutics is doxorubicin (Rang et al., 2003; 
Tan et al., 2009). However, its clinical use is limited due 
to its side effects in high- and repeated-doses. The use of 
the drug induced cardiotoxicity and affected the immune 
functions (Santos et al., 2010; Bowles et al., 2012). 
 Reportedly, doxorubicin suppressed the production of 
IL-2 and INF-gamma, NK cell cytotoxicity, lymphocyte 
proliferation and CD4+/CD8+ ratio in tumour-bearing 
mice (Zhang et al., 2005a). Administration of doxorubicin 
on rats also increase production of pro inflammatory 
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Abstract
 The use of chemotherapeutics induces cardiotoxicity and affects immune functions, therefore development of 
combinatorial agents against cardiotoxicity and immunosuppression needs to be explored. Previous studies of the 
hexane insoluble fraction (HIF) of an ethanolic extract of Ficus septica leaves showed anticancer effects singly 
and in combination with doxorubicin on T47D breast cancer cells. In this present study, it was evaluated for its 
immunomodulatory activities in doxorubicin-treated rats. Thirty male Sprague Dawley  rats were divided into 
five groups consisting of six rats each as follows: Group 1, receiving oral saline 10 ml/kg BW (control group); 
Group 2, receiving HIF dose 750 mg/kg BW orally, once daily; Group 3, receiving HIF dose 1.500 mg/kg BW 
orally, once daily; Group 4, given oral saline 10 ml/kg BW (normal group); Group 5, receiving HIF dose 1.500 
mg/kg BW orally, once daily. The rats of group 1-3 were intramuscularly administered with doxorubicin at a 
dose of 4.67 mg/kg BW at the days 1 and 4 to suppress immune functions. Concomitantly, the rats were treated 
with saline or HIF for seven consecutive days (1 to 7). Treatment of HIF succeeded in reducing side effects of 
doxorubicin based on increasing lymphocyte density and phagocytosis activity and capacity of macrophages, 
as well as increasing the CD8+ blood level and decreasing spleen IL-10 expression. Hexane insoluble fraction of 
of ethanolic extract of Ficus septica leaves has potential as a protective agent combined with doxorubicin. 
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cytokines (Santos et al., 2010). Immunological study on 
advanced breast cancer patients treated with doxorubicin 
showed decreasing plasma level of  IL-1, IL-10, and TNF-
alpha (Panis et al., 2012). The use of chemotherapy is often 
combined with an immunostimulatory agent in order to 
protect and enhance the patients immune functions during 
chemotherapeutics administration. The agent combined 
with chemotherapeutic agents to produce better effects is 
named co-chemotherapeutic agent. 
 Our research group named Cancer Chemoprevention 
Research Center (CCRC) has selected several Indonesian 
plants for their anticancer activity, one of them is Ficus 
septica Burm. F.. In the previous study, ethanolic extract 
of F. septica. showed a cytotoxic effect on MCF-7 and 
T47D cells with IC50 value of 13 and 6 µg/mL, respectively 
(Mubarok et al., 2008; Pratama et al., 2011). The extract 
not only showed a synergistic effect in combination 
with doxorubicin (3.75 nM), but also induced apoptosis 
and downregulated the expression of Bcl-2 protein 
in breast cancer cells MCF-7 (Sekti et al., 2010). In 
7,12-dimethylbenz[a]nthracene-induced rat, the ethanolic 
extract extract at 750 mg/kg BW succeeded to induce 
apoptosis throught p53-independent pathway in liver 
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cancer (Septhea et al., 2011).
 Ethanolic extract of F. septica leaves was gradually 
fractionated to provide several fractions. Among them, 
hexane insoluble fraction has showed most potent 
cytotoxic effect on T47D cell lines (IC50 value : 9 µg/mL) 
and considered to be the active fraction (Nugroho et al., 
2011). The fraction synergically increases the cytotoxic 
effect of doxorubicin through apoptosis, decrease of PARP 
expression and cell cyce arrest (Nugroho et al., 2012). 
Therefore, the fraction is potential to be developed as co-
chemotherapeutic agent for doxorubicin in breast cancer 
therapy. In the present study, the fraction was evaluated for 





 Ficus septica Burm. f. leaves were collected from area 
around Sumber Arum Moyudan, Sleman, Yogyakarta, 
Indonesia. The plant was authenticated by a taxonomist 
at Department of Pharmaceutical Biology, Universitas 
Gadjah Mada, Indonesia. The voucher specimen was 
deposited in herbarium of the department.
Preparation of hexane insoluble fraction (HIF) 
 The fraction was prepared according to the previous 
study (Nugroho et al., 2011). Fresh leaves were washed 
thoroughly with distilled water. The leaves were then 
air dried followed by oven drying at 60 oC. The dried 
leaves were ground and weighed. Subsequently, the dried 
ground powder was extracted using ethanol 70% with a 
ratio of 1:5 for 72 hours. The filtrate was collected, and 
the sediment was re-extracted twice. All filtrates were 
collected and then evaporated under reduced pressure 
to provide a viscous ethanolic extract. The extract was 
diluted with 100 mL aquadest to provide a liquid form of 
that extract. The extract was fractionated with n-hexane 
at a ratio of 1:3 (extract:n-hexane) yielding n-hexane 
soluble fraction and insoluble fraction of n-hexane. The 
insoluble fraction was then concentrated by rotary vacuum 
evaporator at 50 oC (Heidolph Instrument GmbH&Co., 
Germany) to obtain a viscous extract. The fraction was 
dried using a Freeze dryer ALPHA 1-2 LD plus (Martin 
Christ Gefriertrocknungsanlagen GmbH, Germany) in 
order to eliminate the existence of the remaining traces 
of water. 
Animals
 Wistar rats (weighing 100-150 g) were housed at a 
constant temperature (25±2°C) with a constant relative 
humidity (60±10%) on the an automatically controlled 
12:12 h light-dark cycle (light on at 7:00 a.m.). Rats were 
fed with standard rat chow and water as libitum. The rats 
were acclimatized and quarantined for at least one week 
prior to the experiment. 
 The animal handling protocols of this study were in 
accordance with the guidelines of the animal care of the 
Department of Pharmacology and Clinical Pharmacy, 
the Faculty of Pharmacy, Universitas Gadjah Mada, 
Indonesia.
Experimental design
 Thirty male Sprague Dawley  rats were divided into 
five groups consisting of six rats each as follows: Group 1. 
the rats received oral saline 10 ml/kg BW (control group). 
Group 2. the rats received HIF dose 750 mg/kg BW orally, 
once daily. Group 3. the rats received HIF dose 1.500 
mg/kg BW orally, once daily. The rats of group 1-3 were 
intramuscularly administered with doxorubicin (Ebewe, 
obtained from P.T. Ferron Par Pharmaceutical Cikarang, 
Indonesia) dose 4.67 mg/kg BW at the day 1 and 4 to 
suppress the immune functions. Concomitantly, the rats 
were treated saline or HIF for seven consecutive days (day 
1 to day 7). Group 4. the rats received oral saline 10 ml/
kg BW (normal group). Group 5. the rats received HIF 
dose 1.500 mg/kg BW orally, once daily. The rats of group 
4-5 were not treated with doxorubicin. The treatment of 
saline or HIF were administered for seven consecutive 
days. Body weight was monitored regularly.
Lymphocyte proliferation assay
 Rats were sacrificed by decapitation at the day 7. 
Afterwards, the peritoneal cavity was opened carefully, 
and the spleen quickly removed and placed in a tube 
containing RPMI medium to obtain a single cell 
suspension. The cell was then centrifuged at 1500 rpm, 
4°C for 10 min. The pellets were collected and suspended 
in 2 ml of Tris Buffered Ammonium Chloride (8.3 g/L 
ammonium chloride in 0.01 M Tris-HCl buffer pH 7.65) 
to lyse erythrocytes. The cells were mixed gently using 
a pipette and allowed to stand at room temperature for 
5 minutes. Subsequenty, the cells were added with 1 
ml of Fetal Bovine Serum (FBS) (Gibco(R) BRL, USA). 
The suspension was then centrifuged at 1500 rpm, 
4°C for 5 min, and the supernatant was discarded. The 
collected-pellets were washed with RPMI twice, and 
centrifuged. The cell (pellet) was then resuspended with 
complete medium. Cell density was calculated using 
hemocytometer, and its viability was determined by 
tryphan blue. The cells were seeded into 24-well culture 
plates at a density of 106 cells /0.4 ml per each well. The 
cells were incubated overnight at 37 °C for 24, 48, and 72 
hours. Proliferative activity was measured by MTT (3-(4, 
5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) 
(Sigma Chemical, St Loius, MO) test splenocyte assay. 
MTT were added to each well and then incubated for 4 h 
and then added stopper and λ Elisa read at 550 nm.
Macrophage phagocytosis 
 At the day 7, rats were sacrificed by decapitation. 
Macrophages were isolated by injection of cold RPMI-
1640 (Sigma Chem., MO, USA) BSA into the peritoneal 
cavity and the abdomen was massaged for about 3 min. 
The peritoneal cavity was opened carefully, and the fluid 
containing macrophages was collected. The fluid was 
then centrifuged at 1,200 rpm, 40°C for 10 minutes. The 
supernatant was discarded and then resuspended with 
3 ml of complete RPMI medium containing FBS. The 
non-specific phagocytosis activity of macrophages was 
evaluated based on the method of Pratten and Lloyd (1984) 
with a diameter of 3.0 μm latex beads (Sigma Chem., 
MO., USA). Macrophage cells were observed under light 
Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 5787
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.11.5785
Immunomodulatory Effect of Hexane Insoluble Fraction of Ficus Septica Burm. F. on Doxorubicin-treated Rats
microscope for counting the number of phagositic activity 
of macrophages to latex bead particles and the number of 
latex beads phagocited by the macrophages.
Determination of CD8+ lymphocytes 
 At day 0 (basal value) and 7, the blood samples were 
collected from retro-orbital plexus of the rats. The rats 
were anaesthetized using sodium pentobarbital (75 mg/
kg) during blood collections. Sample preparation was 
performed by mixing 5 μl blood sample, 10μL reagent 
rat antigen CD3 fluorescein isothiocyanate (FITC) 
(Invitrogen) and phycoerythrin (PE) anti-rat CD8+ 
(eBioscience) incubated at 5°C for 1 h. After shaking 
gently, the solution was stored in a dark room for 15 
minutes. Subsequenty, the mixture was added with 4,500 
μl lysing solution (BP FACS) for dilution, and vortex, 
then allowed to stand in a dark room for 15 minutes. The 
cells were analyzed with a flowcytometer (FACS Calibur, 
BD) equipped with an argon laser (488 nm excitation) 
and appropriate filter settings for observation of FITC 
fluorescence. The data was the percentage of each type 
of fluorescent cells representing the relative to a number 
of CD8+ T cell lymphocyte.
Immunohistochemical study of IL10
 The spleens were fixed with 4% formaldehyde in 
phosphate-buffered saline (PBS), and gradually dehydrated 
using a series of increasing alcohol concentrations. 
Subsequently, the tissues were cleared using clearing 
agents (xylol), and then embedded in paraffine wax prior to 
subsequent sectioning. Tissue sections 2-3 µm in thickness 
were mounted on glass slides. After washing in phosphate-
buffered saline (PBS), the activity of endogenous 
peroxidase was blocked using 3% H2O2 in methanol for 
15 min, and then washed with aquadest.  Subsequently, 
the sections were incubated with 20% horse serum for at 
least 10 min to prevent non-specific binding. The sections 
were then incubated with Biotinylated rat anti-mouse 
monoclonal antibodies to IL-10 (primary antibodies) at 
a 1:250 dilution for one hour at room temperature. The 
sections was then incubated with peroxidase-conjugated 
secondary antibody at a 1:500 dilution for one hour 
at room temperature. Expression of IL-10 would be 
visualized after incubation with substrate 3,3’-diamino-
benzidine (DAB, Novo Castra) dye for 15 min. The 
sections were counterstained with hematoxylin, and then 
mounted in a mounting medium (Sigma). Expression of 
IL-10 was observed under light microscope. 
Statistical analysis
 All data were presented as mean±the standard error of 
the mean (SEM). One-way analysis of variance (ANOVA) 
followed by the least significant difference (LSD) test 
was used for statistical analysis to compare more than 
two groups. P-values of less than 0.05 were considered 
significant.
Results 
Effect of HIF on lymphocyte proliferation
 In the study, the administration of doxorubicin dose 
4.67 mg/kg BW at the day 1 and 4 succeeded to inhibit 
the proliferation of lymphocytes by 25.77±4.56% 
in comparison to that of control group. Treatment 
of HIF for seven consecutive days in absence of 
doxorubicin did not alter the lymphocytes proliferation 
significantly. Treatment of HIF for seven consecutive days 
concomitantly with doxorubicin at the day 1 and 4 could 
restore the decrease of lymphocytes proliferation due to 
doxorubicin administration in concentration-dependent 
manner (Table 1). Treatment of HIF doses 750 and 1,500 
mg/kg BW succeeded to restore the lymphocytes densities 
of doxorubicin single treatment group by 25.59% and 
52.26%, respectively.
Effect of HIF on macrophage phagocytosis
 The effect of HIF on the phagocytosis of macrophage 
was evaluated using non-specific phagocytosis activity 
on latex beads (Pratten and Lloyd, 1984). In addition, 
the macrophage capacity was also observed. Macrophage 
functions in non-spesific defence (innate immunity) and 
spesific defence (adaptive immunity) in vertebrate animals 
(Rang et al., 2003; Shibata and Glass, 2009; Shalhoub et 
al., 2011). Those cells have a main role in immun system 
as phagocytic cells. In the study, doxorubicin (4.67 mg/
kg BW) administration suppressed phagocytosis activity 
and capacity of macrophages by 27.27±4.21% and 
35.67±3.89%, respectively (Table 2). Single treatment 
of HIF (without doxorubicin administration) did not 
influence the phagocytosis activity and capacity of 
macrophages. Treatment of HIF 1,500 mg/kg BW for 
seven consecutive days concomitantly with doxorubicin 
Table 1. Effect of n-hexane Insoluble Fraction (HIF) of 
F. septica on Lymphocyte Proliferation in Doxorubicin-
induced Rats
Group Treatment Lymphocytes density
  (% control) (Mean±SEM)
I. Doxorubicin 74.23±  3.32#
II. HIF 750 mg/kg+doxorubicin 93.00±13.47
III. HIF 1,500 mg/kg+doxorubicin 113.02±10.21*
IV. HIF 1,500 mg/kg 104.51±  5.57
V. Saline (control) 100.00±  7.88
*Significant difference (P<0.05) compared to the doxorubicin group 
value. #Significant difference (P<0.05) compared to the control (saline) 
value. Data were expressed as Mean±SD (n=4-6 rats) 
Table 2. Effect of n-hexane Insoluble Fraction (HIF) 
of F. septica on Phagocytic of Latex Beads by Rat 
Peritoneal Macrophages in Doxorubicin-induced Rats 
Group Treatment Percentage of Number of latex
  macrophage that beads phagocytosed 
  phagocytose the beads by 100 macrophage 
  (= macrophages capacity) (= phagocytosis activity)
  (Mean±SEM) (Mean±SEM)
I. Doxorubicin 46.93±4.96# 84.71±6.03#
II. HIF 750 mg/kg + doxorubicin 40.56±4.18 70.85±12.87
III. HIF 1,500 mg/kg + doxorubicin 64.35±2.95* 136.71±4.56*
IV. HIF 1,500 mg/kg  62.36±4.56* 148.07±6.56*
V. Saline (control) 64.53±5.20 131.66±10.74
*Significant difference (P<0.05) compared to the doxorubicin group 
value. #Significant difference (P<0.05) compared to the control (saline) 
value. Data were expressed as Mean±SD (n=4-6 rats)
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Figure 1. CD8+ Analysis using Flow Cytometry. The analysis was performed at day 0 (pre-treatment) and the day-7 (post-
treatment) on doxorubicin-treated rats with administration of saline (A), HIF 750 mg/kg BW (B), or HIF 1,500 mg/kg BW (C), or 
on untreated rats with administration of HIF 1500 mg/kg BW (D) or saline (E)
	   	  
	   	  
	  
 Day 0 Day 7 Day 0 Day 7
A) B)
C) D)
 Day 0 Day 7
 E)
succeeded to restore the decreaseasing of phagocytosis 
activity and capacity of macrophages to be the same value 
as control group.
Effect of HIF on CD8+ lymphocytes
 CD8+ lymphocytes is a T lymphocyte that attack 
cancer cells, infected cells and damaged cells (DeNardo 
et al., 2010). In the study, HIF was evaluated for its 
effect on CD8+ profile using a FACS flowcytometer. 
Doxorubicin (4.67 mg/kg BW) administration at the day 
1 and 4 markedly suppressed CD8+ by 38.9±4.23 % in 
comparison to that of control group (Table 3 and Figure 
1). Single treatment of HIF for seven consecutive days 
could increase CD8+ by 16.81±2.79% of control group. 
Treatment of seven consecutive days HIF concomitantly 
with doxorubicin could improve the decrease of CD8+ 
due to doxorubicin administration (Table 3). 
Effect of HIF on spleen IL-10 expression
 Cytokine IL-10, an antiinflammatory cytokine, 
produced mainly by the spleen. In chemotherapy-
treated subjects, there was a significant upregulation 
of cytokines level mainly IL-10 (Zhang et al., 2005a; 
Gotoh et al., 2012). The IL-10 expression in spleen was 
detected by immunohistochemistry staining method 
(Doster et al., 2010). In the study, the suppression of 
immune functions due to doxorubicin treatment were 
accompanied with stimulation of IL-10 expression (Figure 
2a). That stimulation occured when the immune system is 
suppressed in order for defense mechanism in the body. 
Figure 2. Immunohistochemical Study of IL-10 
Expression in Spleen. The analysis was performed on 
doxorubicin-treated rats with administration of saline (a), HIF 
750 mg/kg BW (b), or HIF 1,500 mg/kg BW (c); or on untreated 
rats with administration of HIF 1500 mg/kg BW (d) or saline 
(e). IL-10 expression was showed as a red-brown stained 
mononuclear cells with white (empty) area surrounding the cells 
(red arrow). Magnification of all figures is x 1600
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Table 3. Effect of n-hexane Insoluble Fraction (HIF) of 
F. septica on CD8+ in Doxorubicin-induced Rats. Data 
of CD8+ were Measured at Day 0 (pre-treatment) and 
Day 7 (Post-treatment) 
Group Treatment CD8+ (%) CD8+ (%)
  Day-0 Day-7
  (Mean±SEM)  (Mean±SEM)
I. Doxorubicin 17.62±1.66 10.29±1.45#
II. HIF 750 mg/kg + doxorubicin 18.37±2.10 13.77±2.50*
III. HIF 1,500 mg/kg + doxorubicin 16.40±1.78 15.34±2.81*
IV. HIF 1,500 mg/kg 17.41±2.35 19.66±1.00*
V. Saline (control) 16.55±0.57 16.83±1.74
*Significant difference (P<0.05) compared to the doxorubicin group 
value. #Significant difference (P<0.05) compared to the control (saline) 
value. Data were expressed as Mean±SD (n=3-4 rats)
Single treatment of HIF for seven consecutive days did 
not influence the IL-10 expression in comparison to that 
of control group. Treatment of HIF for seven consecutive 
days concomitantly with doxorubicin mildly decreased 
the stimulation of IL-10 expression due to doxorubicin 
(Figure 2b and 2c).
 
Discussion
In the present study, HIF could restore the immune 
functions that previously suppressed by doxorubicin 
treatement. HIF succeeded to stimulate the lymphocytes 
proliferation and macrophage activation on doxorubicin 
treated rats. In addition,  treatment of HIF reduced the 
decreasing of T cell subsets on observation with FACS 
flowcytometry. Subsequently, HIF was also evaluated for 
its effect on IL-10 that was considered to be responses 
secondary to the increase of T cells. HIF decreased 
the stimulation of IL-10 expression in spleen due to 
doxorubicin treatment. 
Doxorubicin suppressed immune system on 
doxorubicin treated rats, shown by inhibition of 
lymphocyte proliferation, suppression of phagocytosis 
activity and capacity of macrophages, suppression of 
CD8+ cytotoxic T cells and downregulation of IL-10. 
Macrophages play role in non specific immune response 
by phagocytosis, while T cells and B cells are responsible 
for specific immune response. Doxorubicin caused DNA 
damage on bone marrow cells (Uspenskaya et al., 2002), 
and also induced apoptosis on lymphocyte cycle by 
decreasing T cells and B cells in spleen, lymph nodes and 
thymus (Ferraro et al., 2000). Doxorubicin induced ROS 
generation that leads to protein and lipid peroxidation, 
DNA damage, and mitochondrial dysfunction (Ryter and 
Choi, 2012) and increased anti inflammatory cytokine e.g 
IL-10 (Santos et al., 2010). Doxorubicin treatment inhibit 
lymphocyte proliferation on cancer mouse model (Zhang 
et al., 2005b). 
Expression of IL-10 occurred in many cells of adaptive 
immune system such as CD8+ T cells, B cells, and cells 
of the innate immune system such as dendritic cells, 
macrophage, mast cells and natural killer (NK) cells 
(Saraiva and O’Garra, 2010). Upregulation of IL-10 
increased activation and differentiation of CD8+ cytotoxic 
cells (Emmerich et al., 2012). Expression of IL-10 in 
blood is equal to its expression on spleen, the higher IL-
10 expression on spleen, the higher IL-10 expression in 
blood circulation (Min et al., 2004). 
Phytochemical study showed that active compounds 
in the extract of F. septica were compounds of the 
flavonoid and alkaloid, while major compounds of HIF 
are predicted flavonoids. Wu et al. (2002) found out 
the active compounds from Ficus septica leaves i.e. 
phenanthroindolizidine alkaloids, including ficuseptine, 
(+)-tylophorine, and a mixture of (+)-tylocrebrine and 
(+)-isotylocrebrine, that showed potent cytotoxic effect on 
two human cancer cell lines. Some flavonoids including 
genistin, kaempferitrin and coumarin has been also 
identified from leaves of F. septica (Wu et al., 2002). 
Yang et al. (2005) performed anti inflammatory effect of 
F. septica leaves extract through inhibition of inducible 
nitric oxide synthase (iNOS) and cyclooxigenase-2 
(COX-2). However, the exact compounds on HIF need 
to be explored. 
Some f lavonoids  showed  an t icancer  and 
immunomodulatory activity. Previous in vivo anticancer 
combinatorial study of  doxorubicin showed that the 
combination of doxorubicin and proanthocyanidin 
strongly improved the anti-tumour effect of doxorubicin 
and immune responses, and eliminated myocardial 
oxidative stress on rats induced by doxorubicin (Zhang 
et al., 2005a). In vivo study of apigenin on in vitro and 
in vivo genotoxicity showed decreasing doxorubicin 
induced genotoxicity on in vitro model, and decreasing 
genotoxicity on rats induced by cyclophosphamide, 
possibly due to inhibition of chemotherapeutics metabolic 
activation (Bokulić et al., 2011). Another in vivo study 
of flavonoid , showed that single treatment of quercetin 
is able to induce lymphocyte proliferation and regulate 
imbalance of Th1/Th2, while its combination with 
doxorubicin induces persistent T-cell tumor-specific 
responses in breast cancer mouse model (Du et al., 2010). 
Therefore probably flavonoids on HIF also act in the same 
mechanism, but we need to clarified further. 
Based on the results, we concluded that combination of 
n-hexane insoluble fraction (HIF) of Ficus septica Burm. 
F. leaves and doxorubicin provided beneficial effects. HIF 
restored the doxorubicin-induced immunosuppressive 
activities by stimulate the lymphocytes proliferation, 
macrophage activation and T cell subsets, and accompanied 
with mild decrease of IL-10. 
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